Previously, we demonstrated that HLA-DRB1*03+ sarcoidosis patients have an in situ expansion of Vα2.3+Vβ22+ T-cells that recognize vimentin peptides in the context of HLA-DRB1*03. This evidence concerns the gene VIM and sarcoidosis.